What are Digital Therapeutics?
Digital therapeutics (DTx) deliver medical interventions directly to patients smartphones using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders.
DTxs empower patients, clinicians, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions. Amara Therapeutics is a DTx company with a specific focus on pelvic and bladder health.
DTxs empower patients, clinicians, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions. Amara Therapeutics is a DTx company with a specific focus on pelvic and bladder health.
Digital Therapeutic Platforms
Digital Therapeutic Platforms are software solutions with evidence-based therapeutic capabilities. Like in-person therapy or pharmaceuticals, digital therapeutics have a measurable impact on health outcomes.
Clinically Validated
We're committed to testing our interventions in rigorous clinical trials to validate they provide meaningful benefit for patients.
Internationally Regulated
We develop our products in compliance with international regulations and standards such as 21 CFR 820 and Regulation (EU) 2017/745 (EU MDR) to help ensure safety and efficacy.
Amara Therapeutics empowers women to take back control
1 in 4 women suffer from pelvic and bladder health conditions
- Overactive Bladder
- Stress Urinary Incontinence
- Pelvic Organ Prolapse
- Interstitial Cystistis
- Sexual Dysfunction
- Fecal Incontinence
A New Way of Treating Pelvic and Bladder Health Conditions
Accessible
It can be difficult and expensive to access pelvic and bladder healthcare. Digital Therapeutics can revolutionize the treatment of these conditions by providing convenient affordable care direct to your smartphone.
Evidence Based
Behavioral therapy is an effective and safe treatment for Overactive Bladder and is the first-line treatment recommend by international guidelines1.
1International Urogynecological Association (IUGA); International Continence Society (ICS); American Urologic Association (AUA); Canadian Urological Association (CUA).
1International Urogynecological Association (IUGA); International Continence Society (ICS); American Urologic Association (AUA); Canadian Urological Association (CUA).
Developed by Experts
Working with expert clinicians, designers, and engineers, we are designing digital treatments that are empowering, personalized, and effective. We develop our products in compliance with international regulations and standards such as 21 CFR 820 and Regulation (EU) 2017/745 (EU MDR) to ensure our solutions.
Here is what patients have to say about Amara Therapeutics
